(Q51097225)

29 March 2018

title

Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial. (English)

1 reference

29 March 2018

main subject

premenstrual syndrome

1 reference

inferred from title

author

Inger Sundström-Poromaa

series ordinal

1

1 reference

29 March 2018

Torbjörn C. Bäckström

series ordinal

2

object named as

Bäckström T

1 reference

29 March 2018

publication date

1 January 1998

1 reference

29 March 2018

published in

Psychoneuroendocrinology

1 reference

29 March 2018

volume

23

1 reference

29 March 2018

issue

1

1 reference

29 March 2018

page(s)

73-88

1 reference

29 March 2018

The main sequence, a tool for studying human eye movements

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Quantitative measurement of saccade amplitude, duration, and velocity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Effects of steroid hormones on the serotonergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

The human corpus luteum secretes 5 alpha-pregnane-3,20-dione

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Pharmacokinetics and pharmacodynamics of eltanolone (pregnanolone), a new steroid intravenous anaesthetic, in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Challenge tests: assessment of the noradrenergic and GABA systems in depression and anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

The relationship between the menstrual cycle and female sexual interest in women with PMS complaints and volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Commentary. Effect of benzodiazepines upon saccadic eye movements in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Merck, Sharp & Dohme Prize for Young Psychopharmacologists: The pharmacology of saccadic eye movements.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Thyrotropin-releasing hormone selectively reverses lorazepam-induced sedation but not slowing of saccadic eye movements

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Premenstrual depression predicts future major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Estrogen augments serotonergic activity in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Cyclical mood changes as in the Premenstrual tension Syndrome during Sequential Estrogen-Progestagen Postmenopausal Replacement Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Relationship between symptom severity and hormone changes in women with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Modification of saccadic eye movements by GABA-related substances. I. Effect of muscimol and bicuculline in monkey superior colliculus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Benzodiazepine sensitivity in normal human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Acute effects of intravenously given alcohol on saccadic eye movements and subjective evaluations of intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Premenstrual exacerbation of symptoms in women with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Influence of progesterone on serotonin metabolism: a possible causal factor for mood changes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cerebral cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Clinical applications of visual analogue scales: a critical review.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

A risk-benefit appraisal of drugs used in the management of premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

The anaesthetic potency of 3 alpha-hydroxy-5 alpha-pregnan-20-one and 3 alpha-hydroxy-5 beta-pregnan-20-one determined with an intravenous EEG-threshold method in male rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Marked decrease of plasma neuroactive steroids during alcohol withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Reduced benzodiazepine sensitivity in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Effects of treatment with imipramine and clonazepam on an animal model of panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Dorsomedial hypothalamic GABA dysfunction produces physiological arousal following sodium lactate infusions.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900064-4

7 January 2021

10.1016/S0306-4530(97)00064-4

Identifiers

DOI

1 reference

29 March 2018

release_migctgcjpbcdngcpii22vdj3bm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/migctgcjpbcdngcpii22vdj3bm

24 November 2022

mapped directly with Wikidata item

PubMed ID

9618754

1 reference

29 March 2018